Page last updated: 2024-08-21

c.i. 42510 and minocycline

c.i. 42510 has been researched along with minocycline in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fujimoto, N; Fujioka, A; Hiruma, M; Ishibashi, A; Kawada, A; Noguchi, H1
Ducrocq, GP; Estrada, JA; Kaufman, MP; Kim, JS1

Reviews

1 review(s) available for c.i. 42510 and minocycline

ArticleYear
A pediatric case of atypical Mycobacterium avium infection of the skin.
    The Journal of dermatology, 1998, Volume: 25, Issue:6

    Topics: Administration, Oral; Anti-Bacterial Agents; Antitubercular Agents; Buttocks; Child; Coloring Agents; Cutaneous Fistula; DNA, Bacterial; Drug Resistance, Microbial; Female; Granuloma; Humans; Lymphocytes; Minocycline; Mycobacterium avium; Mycobacterium avium-intracellulare Infection; Periodic Acid; Phenols; Rosaniline Dyes; Skin Diseases, Bacterial; Tetracycline Resistance; Thigh

1998

Other Studies

1 other study(ies) available for c.i. 42510 and minocycline

ArticleYear
Intrathecal injection of brilliant blue G, a P2X7 antagonist, attenuates the exercise pressor reflex in rats.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2020, 08-01, Volume: 319, Issue:2

    Topics: Animals; Blood Pressure; Decerebrate State; Injections, Spinal; Male; Minocycline; Physical Conditioning, Animal; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Reflex; Rosaniline Dyes

2020